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  c  represents
  the
  effect
  of
  x
  on
  y
  when
  tobacco
  variables
  (m)
are
  included
  as
  mediators.
  Path
  c
  represents
  the
  effect
  of
  x
  on
  y
  when
  the
  tobacco
  variables
  are
  not
  included
  as
  mediators.
  *p
 <
 .05,
  **p
 <
 .01,
  ***p
 <
 .001.170
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but
  have
  interesting
  implications.
  For
  example,
  a
  recent
  study
  by
van
  der
  Pol
  et
  al.
  (2013)
  found
  that
  current
  problems
  (such
  as
  liv-
ing
  alone,
  coping
  motives
  for
  cannabis
  use
  and
  negative
  life
  events)
were
  better
  predictors
  of
  cannabis
  dependence
  in
  young
  adults
than
  cannabis
  exposure
  itself.
  As
  a
  result
  of
  this
  study,
  we
  included
demographics
  and
  scores
  on
  the
  CTQ
  to
  our
  most
  efﬁcient
  model,
however
  these
  did
  not
  account
  for
  a
  signiﬁcant
  proportion
  of
  vari-
ance
  to
  be
  included
  in
  the
  ﬁnal
  model
  or
  in
  the
  mediation
  analysis.
It
  is
  clear
  that
  CUD
  is
  a
  complex
  disorder
  that
  has
  many
  predictors
and
  vulnerability
  factors
  that
  were
  not
  included
  in
  the
  model.
In
  the
  past,
  regular
  cigarette
  smoking
  would
  precede
  cannabis
use
  (Kandel
  et
  al.,
  1992).
  This
  sequence
  in
  drug
  use
  seems
  to
  be
tapering
  off,
  for
  example,
  around
  1
  in
  5
  young
  cannabis
  users
  have
never
  smoked
  a
  cigarette
  (Suris
  et
  al.,
  2007).
  Interestingly,
  both
cannabis
  and
  tobacco
  smoking
  were
  initiated
  4.9
  and
  4.7
  years
  pre-
viously,
  respectively,
  at
  the
  baseline
  visit,
  suggesting
  simultaneous
age
  of
  onset
  in
  the
  current
  study.
  Therefore,
  these
  results
  do
  not
speak
  to
  sequential
  use
  as
  on
  average
  the
  sample
  initiated
  both
substances
  at
  the
  same
  time.
Stricter
 tobacco
 laws
 in
 some
 countries
 have
 altered
 perceptions
such
  that
  cigarette
  smoking
  is
  considered
  a
  more
  risky
  behaviour
than
  previously.
  In
  2013,
  for
  the
  ﬁrst
  time,
  tobacco
  smoking
  preva-
lence
  was
  estimated
  to
  be
  below
  20%
  in
  the
  UK
  (Brown
  and
  West,
2014).
  In
  comparison,
  cannabis
  use
  has
  become
  normal
  and
  per-
ceptions
  of
  regular
  cannabis
  use
  as
  a
  risky
  behaviour
  are
  at
  an
all-time
  low
  (Johnston
  et
  al.,
  2013)
  with
  risk
  perception
  inversely
related
  to
  prevalence
  of
  cannabis
  use
  (Kleber
  and
  Dupont,
  2012).
This
  may
  be
  due
  to
  the
  shifting
  landscape
  and
  debate
  over
  legali-
sation
  of
  both
  medical
  and
  recreational
  marijuana
  in
  states
  such
  as
Colorado,
  California
  and
  Washington
  in
  the
  United
  States
  as
  well
as
  countries
  such
  as
  Uruguay
  and
  the
  Netherlands
  (Volkow
  et
  al.,
2014).
  As
  a
  result,
  whilst
  tobacco
  smoking
  decreases
  generally,
  it
is
  possible
  that
  tobacco
  use
  will
  also
  increase
  indirectly
  over
  time
due
  to
  increased
  cannabis
  use
  (Patton
  et
  al.,
  2005).
  Our
  ﬁndings
are
  timely
  because
  they
  suggest
  tobacco
  may
  be
  involved
  in
  the
pathogenesis
  of
  CUD,
  a
  possible
  risk
  factor
  of
  legalisation.
Our
 results
 may
 be
 a
 product
 of
 the
 common
 liability
 to
 the
 use
 of
cannabis
 and
 tobacco
 including
 such
 risk
 factors
 like
 shared
 genetic
and
 temperamental
 factors
 (Agrawal
 et
 al.,
 2008,
 2010;
 Brook
 et
 al.,
2010;
  Creemers
  et
  al.,
  2009).
  For
  example,
  recent
  research
  shows
that
  nicotine
  dependence
  was
  associated
  stronger
  with
  lifetime
CUD
  for
  females
  than
  males
  (Blanco
  et
  al.,
  2014).
  Moreover,
  Cooper
and
  Haney
  (2014)
  have
  recently
  demonstrated
  that
  whilst
  subjec-
tive
  effects
  are
  equal
  across
  genders,
  females
  report
  more
  abuse
related
  effects.
  Thus,
  an
  interesting
  analysis
  would
  be
  to
  investi-
gate
  whether
  the
  mediators
  suggested
  in
  the
  present
  study,
  were
stronger
  in
  females
  than
  males
  however,
  given
  that
  the
  sample
was
  71%
  male,
  this
  was
  not
  possible.
  Demographic
  variables
  were
instead
  added
  to
  the
  most
  efﬁcient
  model
  and
  we
  found
  that
  gen-
der
  and
  age
  did
  not
  predict
  cannabis
  dependence
  after
  accounting
for
  cannabis
  and
  tobacco
  use.
  Our
  results
  may
  also
  be
  a
  product
  of
the
  common
  route
  of
  administration
  (Agrawal
  and
  Lynskey,
  2009)
where
  inhalation
  of
  one
  substance
  may
  sensitise
  an
  individual
  to
the
  inhalation
  of
  another
  substance.
4.1.
  Strengths
  and
  limitations
This
  study
  has
  several
  strengths
  including
  a
  relatively
  large
sample
  size
  of
  298
  young
  cannabis
  and
  tobacco
  users
  assessed
  in
their
 own
 homes.
 Moreover,
 we
 used
 continuous
 variables
 to
 index
both
  cannabis
  and
  tobacco
  smoking
  making
  it
  possible
  to
  assess
the
  relationship
  between
  drug
  use
  variables
  at
  varying
  levels
  of
severity
  (Ramo
  et
  al.,
  2013).
  This
  study
  also
  suffers
  from
  several
limitations.
  First,
  within
  our
  exploratory
  follow-up
  sample
  we
  had
a
  modest
  response
  from
  65
  participants.
  This
  may
  have
  reduced
the
  power
  to
  detect
  a
  possible
  true
  effect
  of
  baseline
  cannabis
  use
on
  future
  dependence
  (for
  example,
  surprisingly,
  days
  of
  cannabis
use
  per
  month
  at
  baseline
  were
  not
  associated
  with
  cannabis
dependence
  at
  follow
  up)
  and
  therefore
  these
  exploratory
  follow-
up
  results
  should
  be
  interpreted
  with
  caution
  until
  they
  can
  be
replicated
  with
  a
  greater
  sample
  size.
  Moreover,
  we
  were
  unable
  to
control
  for
  the
  simultaneous
  use
  of
  cannabis
  and
  tobacco
  (joints)
as
  the
  route
  of
  administration
  and
  as
  a
  necessity
  our
  sample
  is
limited
  those
  who
  only
  smoke
  cannabis
  and
  tobacco.
  These
  results
should
  be
  interpreted
  within
  their
  self-reported
  context.
  Finally,
the
  multiple
  mediation
  analysis
  was
  conducted
  on
  cross
  sectional
data
  and
  therefore
  the
  existence
  and
  direction
  of
  causality
  cannot
be
  discerned.
4.2.
  Conclusions
In
  light
  of
  the
  medicalisation
  and
  legalisation
  of
  marijuana,
research
  on
  cannabis
  and
  tobacco
  use
  is
  essential.
  In
  a
  natural-
istic
  study
  of
  cannabis
  and
  tobacco
  co-users,
  baseline
  cigarette
smoking
  (frequency
  and
  years)
  predicts
  cannabis
  dependence
  con-
currently
  when
  controlling
  for
  frequency
  of
  cannabis
  use;
  however
this
  was
  no
  longer
  the
  case
  four
  years
  later.
  At
  baseline,
  cigarette
smoking
  mediated
  the
  relationship
  between
  cannabis
  use
  and
cannabis
  dependence,
  even
  when
  controlling
  for
  psychological
and
  demographic
  correlates
  that
  might
  explain
  this
  relationship.
This
  suggests
  that
  cigarette
  smoking
  enhances
  vulnerability
  to
  the
harmful
  effects
  of
  cannabis.
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